What is Keratoconus (KC) ?什么是圆锥角膜(KC)?

What is Keratoconus (KC) ?什么是圆锥角膜(KC)?

Keratoconus (KC) is a progressive, bilateral (often asymmetrical) ectatic corneal disorder characterized by progressive thinning and steepening of the cornea, transforming its normal dome shape into a conical structure and causing irregular astigmatism and visual degradation. Understanding its biomechanical origin is essential for selecting appropriate therapies that halt disease progression while optimizing optical rehabilitation.
圆锥角膜(KC)是一种进行性、双眼(通常不对称)的角膜扩张性疾病,其特征为角膜局灶性变薄和突起,使正常的圆顶状角膜塑变为锥形,从而引发高度不规则散光和视力严重下降。 深入理解其生物力学机制,是选择针对性治疗(遏制病程恶化与进行高阶光学重塑)的核心前提。

Pathophysiology & Disease Drivers 圆锥角膜三大病理机制与物理促发因素

Corneal Biomechanical Instability 角膜生物力学稳定性缺失

Downregulation of structural collagen fibers and loss of keratocytes reduce stromal tensile strength, leading to progressive tissue slippage and corneal bulging under normal intraocular pressure.

结构性胶原纤维表达下调与角膜基质细胞丢失,降低了基质层的抗张强度,导致角膜在正常眼压下发生渐进性组织滑移与向前圆锥状膨隆。

Mechanical Micro-Trauma (Eye Rubbing) 机械性微创伤(频繁揉眼)

Persistent physical friction from chronic eye rubbing releases inflammatory cytokines, elevates corneal surface temperature, and mechanically disrupts collagen lamellae, accelerating biomechanical degradation.

长期揉眼产生的机械摩擦力会释放炎性细胞因子、升高角膜表面局部温度,并物理性破坏胶原层板结构,是加速角膜扩张恶化的主要行为诱因。

Oxidative Stress & Proteolytic Imbalance 氧化应激与蛋白酶解失衡

Increased levels of reactive oxygen species (ROS) combined with elevated matrix metalloproteinases (MMPs) cause enzymatic digestion and degradation of the corneal extracellular matrix.

活性氧(ROS)水平升高联合基质金属蛋白酶(MMPs)活性增强,导致角膜细胞外基质发生酶解破坏与过度降解。

Visual & Refraction Degradation 屈光表型与高阶像差破坏

The conical deformation disrupts the eye's uniform refractive surface, driving rapid myopic progression, high irregular astigmatism, and severe higher-order aberrations (diplopia, glare, halos).

角膜锥形变性破坏了眼表平滑统一的屈光面,引发近视度数快速加深、高度不规则散光以及严重的单眼复视、眩光和光晕等高阶像差。

Matrix of Clinical Intervention四大临床干预手段汇总对照表

Intervention 干预方式 Main Objective 主要治疗目标 Action Mechanism 作用机制 Halts Progression? 能否遏制病程恶化?
Corneal Cross-Linking (CXL)
角膜交联术
Disease stabilization
稳定控制病情发展
Creates covalent bonds across stromal collagen using UVA + Riboflavin.
利用紫外线 A (UVA) 激活核黄素,在基质胶原间建立化学共价键。
Yes (Primary therapeutic standard)
(金标准治疗)
Scleral Contact Lenses
巩膜镜/特种接触镜
Visual rehabilitation
光学重塑与视力矫正
Vaults over cornea; fluid reservoir masks irregular corneal topography.
跨越角膜拱挂于巩膜,液态水库掩模填补不规则角膜地形。
No (Improves vision; does not stiffen tissue)
不能(提升视力,不改变角膜硬度)
Allergy Control & Habit Change
抗过敏治疗与行为干预
Risk & trauma reduction
降低风险与机械损伤
Eliminates mechanical trauma and inflammatory cytokine release from rubbing.
消除揉眼带来的机械创伤及炎性细胞因子释放。
Yes (Prevents mechanical acceleration)
(防止机械性加速恶化)
Surgical Graft (DALK / PKP)
角膜移植术(DALK / PKP)
Advanced tissue replacement
终末期角膜组织置换
Replaces scarred/thinned stroma with clear donor tissue.
用透明供体角膜置换已形成瘢痕或极度变薄的病变基质。
N/A (End-stage intervention)
不适用(终末期挽救手段)

High Prevalence Demographics & Risk Associations:
高发人群特征与易感相关因素:

  • Age Profile & Geographic Patterns: Onset typically occurs during puberty or early adulthood (ages 10–25), progressing into the 30s–40s. Consistently higher prevalence is reported in sunny, warm climates (e.g., Middle East, South Asia).
    发病年龄与地理差异: 发病常始于青春期或青年期(10-25岁),并持续恶化至30-40岁。在中东、南亚等日照强、气候炎热地区的患病率显著高于北欧。
  • Ocular Allergies & VKC: Chronic ocular surface inflammation (Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis/VKC) and associated persistent eye rubbing act as primary environmental triggers.
    眼部过敏与春季角结膜炎(VKC): 慢性眼表炎症及由此引发的持续性揉眼行为,是驱动角膜扩张最核心的后天环境因素。
  • Systemic & Syndromic Associations: Significantly higher prevalence is observed in patients with systemic connective tissue and genetic conditions, including Down syndrome, Marfan syndrome, Ehlers-Danlos syndrome, and severe atopy.
    全身性与遗传综合征关联: 在唐氏综合征、马凡氏综合征、埃勒斯-当洛丝综合征(EDS)及严重特应性体质患者中,圆锥角膜的发病率大幅升高。

Q&As 常见疑问解答

Q1: "Why can't my vision be fully corrected with standard glasses or soft contact lenses anymore?" 问:为什么普通的框架眼镜或普通软性隐形眼镜再也无法帮我矫正到清晰视力了?

Standard glasses and soft contact lenses can only correct regular, symmetrical optical refractive errors.

As keratoconus progresses, the localized thinning causes the cornea to bulge unevenly, creating an asymmetrical "cone" shape with severe irregular astigmatism and higher-order visual aberrations. Standard glasses lenses provide a uniform smooth surface, but cannot compensate for the microscopic bumps and steep slopes of an irregular corneal topography. Soft contact lenses simply drape over and mirror the bumpy shape of your irregular cornea. To achieve crisp vision, specialized rigid gas permeable (RGP) or scleral contact lenses are required to bridge over the irregularity.

普通框架眼镜和软性隐形眼镜仅能矫正规则、对称的屈光不正(如普通的近视和规则散光)。

随着圆锥角膜的发展,局灶性变薄会导致角膜表面发生非对称性的“锥形”隆起,产生大量的不规则散光和高阶像差。框架镜片只能提供统一平整的屈光度,无法抵消角膜表面微观上的凹凸不平;而普通的软性隐形眼镜会顺应并贴合角膜的不规则形状,无法改变其畸变。要恢复清晰视力,必须借助硬性透氧接触镜(RGP)或巩膜镜来重新塑造一个平滑的光学界面。

Q2: "Does wearing Scleral Lenses or RGP lenses stop my keratoconus from getting worse over time?" 问:配戴巩膜镜(Scleral Lenses)或 RGP 硬镜能阻止我的圆锥角膜继续恶化加重吗?

No. Specialty contact lenses are optical rehabilitation devices that restore functional vision—they do NOT structurally reinforce or stop the biological progression of keratoconus.

Scleral lenses vault completely over the irregular cornea and rest on the insensitive sclera, creating a liquid reservoir that masks optical irregularities. While they provide exceptional visual acuity and protect the corneal surface from atmospheric friction, they do not alter corneal collagen biomechanics. To biologically stop the progressive weakening of corneal tissue, surgical interventions such as Corneal Collagen Cross-Linking (CXL) must be performed.

不能。特种接触镜属于光学矫正与视力重塑工具,它们完全无法从结构上增强角膜硬度,也无法阻断圆锥角膜的生物学恶化进程。

以巩膜镜为例,它完全拱挂跨越不规则的角膜,将镜片着陆点放在不敏感的巩膜上,利用镜片与角膜之间的液体水库填平角膜表面的凹凸不平。虽然它能带来极佳的视力和防护作用,但它并没有改变角膜胶原纤维的生物力学强度。要从生物学根源上阻止角膜进一步变薄变陡,必须接受角膜胶原交联术(CXL)治疗。

Q3: "How exactly does Corneal Collagen Cross-Linking (CXL) work to stabilize my eyes, and when should it be performed?" 问:角膜胶原交联术(CXL)具体是如何控制病情的?应该在什么时机接受治疗?

CXL is currently the only medical intervention proven to halt progressive keratoconus by chemically stiffening corneal tissue.

During the CXL procedure, Riboflavin (Vitamin B2) photosensitizing liquid is applied to the corneal stroma and activated by Ultraviolet-A (UVA) light. This reaction releases reactive oxygen species that form covalent chemical cross-links between individual collagen fibrils, effectively "freezing" the corneal shape and boosting its structural rigidity. CXL should be performed as soon as documented progression (progressive corneal thinning or steepening on topography) is confirmed, especially in younger patients who face higher risks of rapid progression.

CXL 是目前全球唯一经过医学证实、能够通过化学硬化角膜组织来控制圆锥角膜恶化的治疗手段。

在 CXL 过程中,医务人员会将核黄素(维B2)滴入角膜基质层,并使用紫外线 A(UVA)照射激活。此过程会促使角膜胶原纤维之间建立全新的化学共价键(交联),如同为松散的织物加上了加强筋,大幅提升角膜的抗张强度。只要通过角膜地形图检查确诊病情处于进行性加重阶段,就应尽早实施 CXL,尤其是对于病情恶化极为迅速的青少年及年轻患者。

Q4: "Is eye rubbing really that dangerous for someone with keratoconus, or is it just a minor bad habit?" 问:对于圆锥角膜患者来说,揉眼真的有那么危险吗?还是这只是一种无伤大雅的小习惯?

Eye rubbing is one of the single most dangerous physical drivers of keratoconus progression and must be completely stopped immediately.

Frequent, vigorous eye rubbing causes mechanical micro-trauma: it physically shears fragile collagen lamellae, spikes intraocular hydrostatic pressure, raises corneal surface temperatures, and triggers the release of tissue-degrading inflammatory cytokines (such as MMP-9). This combination severely accelerates stromal collagen loss and corneal ectasia. If persistent itchiness from allergies is driving you to rub your eyes, anti-allergic eye drops (mast cell stabilizers/antihistamines) must be prescribed to eliminate the itch and protect your corneas.

揉眼是导致圆锥角膜快速恶化的最危险物理诱因之一,必须绝对禁止。

频繁、剧烈的揉眼会导致严重的机械微创伤:它会物理性剪切脆弱的胶原层板、使眼内水压瞬间飙升、升高角膜局部温度,并刺激释放可降解角膜组织的炎性因子(如 MMP-9)。这些因素叠加会剧烈加速角膜基质的流失与变形。如果是眼部过敏瘙痒导致您忍不住揉眼,必须立即请医生开具抗过敏眼药水(肥大细胞稳定剂/抗组胺药)止痒,从根源上杜绝揉眼行为。

Q5: "Will I eventually need a full corneal transplant (graft) surgery if I have keratoconus?" 问:得了圆锥角膜,我最终一定需要做角膜移植手术吗?

No. Thanks to early diagnostic topography and cross-linking (CXL), the vast majority of keratoconus patients will never require a corneal transplant.

Corneal transplants (such as Deep Anterior Lamellar Keratoplasty [DALK] or Penetrating Keratoplasty [PKP]) are reserved solely for advanced, end-stage cases where severe apical scarring obstructs vision, extreme thinning makes CXL unsafe, or specialty contact lenses can no longer be safely fitted. By managing allergies early, stopping eye rubbing, undergoing CXL when progression is detected, and fitting customized scleral lenses, most patients maintain functional visual acuity for life without surgical transplantation.

绝大多数患者并不需要。得益于早期角膜地形图诊断技术以及 CXL 角膜交联术的普及,绝大多数圆锥角膜患者终生都不需要走上角膜移植这条路。

角膜移植手术(如深层前板层角膜移植术 DALK 或穿透性角膜移植术 PKP)仅作为终末期的救救性手段,用于处理严重锥顶瘢痕遮挡视线、角膜极度变薄无法安全实施 CXL、或已无法安全配戴特种接触镜的晚期患者。只要能早期控制过敏、彻底戒除揉眼、在恶化初期及时接受 CXL 并规范配戴巩膜镜,绝大多数患者都能长期保持极佳的视力生活。

Jul 31,2026